Herlina Dimiati

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 5

Top Topics

Respiratory Syndrome Coronavirus

Nitric Oxide Synthase

Pulmonary Hypertension

Top Venues

Vascular health and risk management

The Egyptian heart journal : (EHJ) : official bulletin of the Egyptian Society of Cardiology

This page only lists publications with an associated author ORCID identifier.

Publications

Teuku Heriansyah, Herlina Dimiati, Tjut Farahiya Hadi, Dimas Arya Umara, Lian Varis Riandi, Fauzan Fajri, Sukmawan Fajar Santosa, Titin Andri Wihastuti, Kumboyono Kumboyono
Ascorbic Acid vs Calcitriol in Influencing Monocyte Chemoattractant Protein-1, Nitric Oxide, Superoxide Dismutase, as Markers of Endothelial Dysfunction: In Vivo Study in Atherosclerosis Rat Model. Vascular health and risk management 19 (2023)
Muhammad Ridwan, Herlina Dimiati, Maimun Syukri, Ronny Lesmana
Potential molecular mechanism underlying cardiac fibrosis in diabetes mellitus: a narrative review. The Egyptian heart journal : (EHJ) : official bulletin of the Egyptian Society of Cardiology 75 (1) (2023)
Teuku Heriansyah, Herlina Dimiati, Tjut Farahiya Hadi, Dimas Arya Umara, Lian Varis Riandi, Fauzan Fajri, Sukmawan Fajar Santosa, Titin Andri Wihastuti, Kumboyono Kumboyono
Ascorbic Acid vs Calcitriol in Influencing Monocyte Chemoattractant Protein-1, Nitric Oxide, Superoxide Dismutase, as Markers of Endothelial Dysfunction: In Vivo Study in Atherosclerosis Rat Model. Vascular health and risk management 19 (2023)
Herlina Dimiati, Dimas Arya Umara, Iflan Naufal
Covid-19-induced pulmonary hypertension in children, and the use of phosphodiesterase-5 inhibitors. F1000Research 10 (2022)
Herlina Dimiati, Dimas Arya Umara, Iflan Naufal
Covid-19-induced pulmonary hypertension in children, and the use of phosphodiesterase-5 inhibitors. F1000Research 10 (2022)